Bittersweet Medicine
A toddler with a rare condition has become the first child treated in the UK with a life-saving gene therapy. The drug costs Β£3m per patient. Βι¶ΉΤΌΕΔ medical editor Fergus Walsh has this exclusive report.
A toddler with a rare and devastating inherited condition has become the first child to be treated in the UK with a life-saving gene therapy. The drug, called Libmeldy, is the most expensive medicine in Europe, costing nearly Β£3m per patient. For the family it is bittersweet as only one of the two children can be saved. The Βι¶ΉΤΌΕΔ’s medical editor Fergus Walsh has followed the treatment at Royal Manchester Children’s Hospital over several months and has this exclusive report.
Last on
Broadcasts
- Wed 15 Feb 2023 20:30GMTΒι¶ΉΤΌΕΔ News UK HD & UK only
- Sat 18 Feb 2023 16:30GMTΒι¶ΉΤΌΕΔ News UK HD & UK only
- Sun 19 Feb 2023 00:30GMTΒι¶ΉΤΌΕΔ News UK HD & UK only
- Sun 19 Feb 2023 15:30GMTΒι¶ΉΤΌΕΔ News UK HD & UK only
- Mon 20 Feb 2023 03:30GMTΒι¶ΉΤΌΕΔ News UK & UK HD only
Featured in...
Behind the Medicine
The latest developments in the medical world uncovered.
A Matter of Life and Health
Global breakthroughs, thought provoking experiments, and medical triumphs